update on tirzepatide lawsuit Eli Lilly sues companies selling alternative versions of its weight loss drug : Shots Zepbound Lawsuit [2026] | Gastrointestinal

The most common effects are mild injection site reactions (temporary redness or slight discomfort), occasional mild water retention (often temporary and dose-dependent), rare reports of mild tingling or numbness in extremities (usually transient), mild increases in hunger in some subjects (less common than with GHRP-6), and occasional mild headaches (often resolve quickly)

NATA accredited

If appetite wanes in the evening, as it does for some on retatrutide, a light dinner or even a late-night snack can be skipped

The confound: a lower dose of citrulline malate

A flow chart illustrating selection of the study cohort is shown in Fig